Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
2827435 | Blood Cells, Molecules, and Diseases | 2010 | 4 Pages |
Abstract
Gene fusion is a very rare mechanism that produces hemoglobin variants. Less than ten types of β-like hybrid globins have been reported to date. Herein we identified the first hybrid hemoglobin between Gγ- and β-globins in a five-year-old Korean male who had thalassemia minor feature and triplication of the HBA2 gene (αα/αααα). The novel globin originated from a 27,707-base pair deletion spanning from the HBG2 to HBB gene (NG_000007.3:g.42947_70653del). Its protein sequence included 13 N-terminal amino acids from Gγ-globin, five common amino acids from Gγ- and β-globins, and 128 amino acids from β-globin (Gγ through 13; β from 19). Molecular genetic analyses characterized the hybrid DNA and RNA. Mass spectrometry and de novo protein sequencing successfully identified the fusion peptide in the hybrid hemoglobin. We named this novel hybrid Hb Gγ-β Ulsan. The novel hemoglobin constituted 37.0% of the total hemoglobin and showed reduced oxygen affinity.
Keywords
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Molecular Biology
Authors
So Yeon Kim, Seon Ho Lee, Sung Im Cho, Sang Hoon Song, Yukio Hattori, Sang-Kyu Park, Junghan Song, Yangsun Choi, Mangil Yang, Hyunwoong Park, Sung-Ryul Kim, Moon-Woo Seong, Ji Yeon Kim, Han-Ik Cho, Sung Sup Park,